Overview

ENDP Q4 and Full-Year 2016 Slides
J.P. Morgan Healthcare Conference Presentation – January 9, 2017
Final ENDP Q3 2016 Slides

Endo International plc is a global specialty pharmaceutical company focused on improving patients’ lives while creating shareholder value. Endo develops, manufactures, markets and distributes quality branded pharmaceutical and generic pharmaceutical products as well as over-the-counter medications through its operating companies. Endo International is headquartered in Dublin, Ireland. U.S. headquarters are in Malvern, PA.


Stock Quote
NDAQ: ENDP (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$9.97
Change (%) Stock is Down 0.02 (0.20%)
Volume5,900,506
Data as of 03/24/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
Mar 14, 2017Endo Statement On FDA Advisory Committees' Vote Related To OPANA® ERPrinter Friendly Version
Mar 03, 2017Endo International plc To Delist Ordinary Shares From The Toronto Stock ExchangePrinter Friendly Version
Feb 28, 2017Endo Reports Fourth-Quarter And Full-Year 2016 Financial ResultsPrinter Friendly Version
Feb 24, 2017Endo Pharmaceuticals Inc. Issues Voluntary Nationwide Recall for One Lot of Edex® (alprostadil for injection) 10 mcg 2 Pack Carton Due to Potential Lack of Sterility AssurancePrinter Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
What's New
Download Documentation 2015 Annual Report
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Endo International plc posts new information to the site. Just enter your e-mail address and click Submit.
 
Investor Relations Contacts:
Stephen Mock
Senior Vice President, Investor Relations and Corporate Affairs
845-364-4833
E-mail: mock.stephen@endo.com

Nina Goworek
Senior Director, Investor Relations
484-216-6657
E-mail: goworek.nina@endo.com

Heather Zoumas Lubeski
Senior Director, Corporate Affairs
484-216-6829
E-mail: zoumaslubeski.heather@endo.com


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Print Page Print Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet